Search results for: cancer prevention agent development

SOURCES SOUGHT (Small Business): On behalf of the National Cancer Institute (NCI), Division of Cancer Prevention (DCP)TITLE: “Regulatory Support for Cancer Prevention Agent Development”INTRODUCTIONThe National Institutes of Health (NIH) National Cancer Institute (NCI), Division of Cancer Prevention (DCP) is issuing this Sources Sought as a means of conducting market research to invite participation from all Small Business concerns that are engaged

CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH Solicitation ID/Procurement Identifier: N01CN0501469 Ultimate Completion Date: Fri Sep 22 17:00:00 GMT 2023

CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM Solicitation ID/Procurement Identifier: N01CN0501469 Ultimate Completion Date: Fri Sep 22 17:00:00 GMT 2023

OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH Solicitation ID/Procurement Identifier: HHSN261201200034I Ultimate Completion Date: Tue Sep 22 17:00:00 GMT 2020

of current topics, progress, and opportunities in cancer preventive agent development research.Background:The National Cancer Institute (NCI), Division of Cancer Prevention (DCP) has over 40 active clinical trials, 15 trials in development and is the sponsor for approximately 35 INDs (Investigational New Drug Applications).

McLaurin, Contracting Officer, Phone 240-276-5438, Email mclaurinsm@mail.nih.gov - Wanda Neal, Contracting Officer, Phone 301-435-3804, Fax 301-480-0309, Email wn21j@nih.gov Office Address :9609 Medical Center Drive, Room 1E128 Rockville MD 20852 Location: National Cancer Institute, Office of Acquisitions Set Aside: Award Number: 75N91018C00017 Award Amount : $13,846,650

A one year cost plus fixed fee Contract (with four option years) for Regulatory Support for Cancer Prevention Agent Development was awarded to CCS Associates, Inc. on September 14, 2023 in the amount of $2,975,011.